Bellevue Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-10,628
| Closed | -$296K | – | 133 |
|
|
2017
Q4 | $296K | Sell |
10,628
-3,800
| -26% | -$106K | 0.03% | 134 |
|
|
2017
Q3 | $494K | Hold |
14,428
| – | – | 0.05% | 123 |
|
|
2017
Q2 | $575K | Hold |
14,428
| – | – | 0.07% | 123 |
|
|
2017
Q1 | $531K | Sell |
14,428
-1,000
| -6% | -$36.8K | 0.07% | 121 |
|
|
2016
Q4 | $492K | Sell |
15,428
-3,000
| -16% | -$95.7K | 0.1% | 112 |
|
|
2016
Q3 | $668K | Buy |
18,428
+7,000
| +61% | +$254K | 0.12% | 110 |
|
|
2016
Q2 | $259K | Buy |
11,428
+180
| +2% | +$4.08K | 0.05% | 118 |
|
|
2016
Q1 | $215K | Buy |
+11,248
| New | +$215K | 0.04% | 121 |
|